Atropos Health Shares Real-World Evidence Examining High vs Low-Cost Medications

In a poster session at this year’s American Society of Health-System Pharmacists (ASHP) meeting, Atropos Health presented real-world evidence examining the impact of prescribing high-cost vs low-cost medications on patient health outcomes. The study, which looked at electronic health records (EHR) taken between 2015 and 2021, found no difference in outcomes between drugs at different price brackets.

According to Atropos Health, “Clinicians and their healthcare institutions are better able to unlock the value of evidence-based practice with Atropos, as its Evidence Platform securely automates the real-world data analytics process. Proprietary technology for medical data search, rapid cohorting, electronic phenotyping, and advanced analytics combine to form an engine for critical healthcare insights. Atop the technologic complexity sits an intuitive Q&A interface. Thousands of clinicians can simply press a ‘Green Button’ to submit study questions, such as underlies the publication here, and receive evidence from the EHR within 48 hours. The inability to rapidly generate these observational studies has long been a barrier to implementing insights from the EHR into clinical practice. Now, that barrier is dissipating.”

To read more, click here.

(Source: PR Newswire, June 12^th, 2023)